Serum Helicobacter Pylori FliD Antibody and the Risk of Gastric Cancer

Oncotarget - United States
doi 10.18632/oncotarget.7981
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Economic Evaluation of Using a Combination of Helicobacter Pylori Antibody and Serum Pepsinogen Levels for Gastric Cancer-Risk Screening in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Helicobacter Pylori and Early Gastric Cancer.

Gut
Gastroenterology
1994English

Helicobacter Pylori Infection and Gastric Cancer.

Internal Medicine
Internal MedicineMedicine
2002English

Characteristics of Gastric Cancer in Endoscopic Screening With Combined Serum Assay for Anti-Helicobacter Pylori Antibody and Pepsinogen Levels

Health Evaluation and Promotion
2015English

Serum Neutralizing Antibody Response to the Vacuolating Cytotoxin of Helicobacter Pylori.

Journal of Clinical Investigation
Medicine
1992English

Prospective Study of Helicobacter Pylori Biomarkers for Gastric Cancer Risk Among Chinese Men

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

The Role of the Gastric Bacterial Microbiome in Gastric Cancer: Helicobacter Pylori and Beyond

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

Distinct Clinicopathological Features and Prognosis of Helicobacter Pylori Negative Gastric Cancer

PLoS ONE
Multidisciplinary
2017English

Helicobacter Pylori Infection Following Endoscopic Resection of Early Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy